[1] |
WANG Yan, ZHANG Jinhui, ZHAO Yongchen, LIU Hongxiang, LIU Yawei, MIAO Huanhuan, YANG Xincai.
Sequoiaflavone inhibits stem cell properties such as proliferation and invasion of gastric cancer cells by down-regulating PI3K/AKT signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 508-513.
|
[2] |
WANG Dan, YAN Xiaoli, ZHANG Yuan.
Helicobacter pylori infection influences the efficacy of immunotherapies for gastric cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 228-234.
|
[3] |
LIU Le, QI Wenbo, BAI Yuping, LIU Qian, YIN Zhenyu, LI Xiaomei, YU Yang, CHEN Hao.
Influencing factors of PD-1/PD-L1 immune checkpoint inhibitor immunotherapy for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 95-101.
|
[4] |
WANG Yaya, CHU Zixuan, YANG Junling, Olajide E. Olaleye, HE Rongrong, LI Muzi, CHENG Chen, LI Chuan.
Potential health benefits of resveratrol: a pharmacokinetics-caused conundrum
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 931-954.
|
[5] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[6] |
Pazilaiti YASEN, YUAN Hao, LU Hong, ZHENG Ya, WANG Yuping, ZHOU Yongning.
Research progress in clinical trials of targeted drugs for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 454-461.
|
[7] |
DENG Li, TIAN Jing.
Resveratrol suppresses NLRP3 inflammasome activation in colonic epithelial cells triggered by Escherichia coli O104∶H4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 167-173.
|
[8] |
YUAN Lijialong, YUAN Ronghui, WANG Jin, DENG Ziwei, WANG Hongqiang, DENG Ye, GONG Lu, JIN Yuanxiang, SHI Zhihua.
Effects of resveratrol on autophagy of tumor cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1066-1073.
|
[9] |
JIANG Weiyu, HU Xudong, CHEN Yunlin, RUAN Chaoyue, XU Nanjian, WANG Yang, XU Dingli, ZHANG Jiaming, LI Haojie, MA Weihu.
Esveratrol inhibits NLRP3 inflammasome activation in rabbits with spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 850-856.
|
[10] |
TIAN Dahao, LU Linming, ZHI Hui, ZHOU Jue, WANG Xiaoqing, JIANG Yuhua.
AHVAC-I inhibits the proliferation in human primary gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 505-511.
|
[11] |
SHEN Cheng, YANG Nianzhao, WANG Minghai, WU Lisheng, ZHU Zhiqiang.
Inhibiting RNA methylase NSUN2 reduce the invasion and migration of gastric cancer cell
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 380-386.
|
[12] |
WU Qiaoyu, YUAN Hong, LU Yao.
Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 426-432.
|
[13] |
ZHOU Haiyan, WANG Kailing .
Resveratrol protects human retinal pigment epithelial cells from toxicity of high glucose by up-regulation of miR-26a
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 285-292.
|
[14] |
SONG Hui, WANG Yinghao.
Resveratrol inhibits the proliferation of retinoblastoma cells via miR-937/FOXQ1 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 174-181.
|
[15] |
LIU Yujia, LI Li, HU Xiaoping, ZHONG Like, LI Jingjing, HUANG Ping, ZHANG Yiwen.
A correlation analysis between survival rate and the characteristic gene of gastric cancer based on bioinformatics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 852-859.
|